Premium
Cogent Biosciences Inc (COGT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| FMR LLC | Institution | 23 122 660 | 13,53% | US$ 889,76M | 2026-03-31 |
| BlackRock, Inc. | Institution | 16 045 014 | 9,39% | US$ 617,41M | 2026-03-31 |
| Commodore Capital Master LP | Institution | 9 602 000 | 5,62% | US$ 369,48M | 2025-09-30 |
| Deerfield Management Company, L.P. | Institution | 9 043 903 | 5,29% | US$ 348,01M | 2026-03-31 |
| Deerfield Partners, LP | Institution | 9 043 903 | 5,29% | US$ 348,01M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 7 333 333 | 4,29% | US$ 282,19M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 6 894 959 | 4,03% | US$ 265,32M | 2026-03-31 |
| The Column Group, LLC | Institution | 6 798 162 | 3,98% | US$ 261,59M | 2025-09-30 |
| TCG Crossover Fund I, L.P. | Institution | 6 798 162 | 3,98% | US$ 261,59M | 2025-09-30 |
| Janus Henderson Group plc | Institution | 5 965 125 | 3,49% | US$ 229,54M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 5 926 826 | 3,47% | US$ 228,06M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 5 663 543 | 3,31% | US$ 217,93M | 2026-03-31 |
| Fairmount Funds Management LLC | Institution | 5 542 832 | 3,24% | US$ 213,29M | 2026-03-31 |
| Fairmount Healthcare Fund II L.P. | Institution | 5 542 832 | 3,24% | US$ 213,29M | 2026-03-31 |
| RTW Investments, LP | Institution | 5 458 675 | 3,19% | US$ 210,05M | 2026-03-31 |
| Commodore Capital LP | Institution | 5 240 007 | 3,07% | US$ 201,64M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 4 946 894 | 2,89% | US$ 190,36M | 2026-03-31 |
| Paradigm BioCapital International Fund Ltd. | Institution | 4 906 897 | 2,87% | US$ 188,82M | 2025-02-05 |
| Kynam Capital Management, LP | Institution | 4 037 331 | 2,36% | US$ 155,36M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 4 032 988 | 2,36% | US$ 155,19M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 3 699 519 | 2,16% | US$ 142,36M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 3 578 622 | 2,09% | US$ 137,71M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 3 212 815 | 1,88% | US$ 123,63M | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 3 181 270 | 1,86% | US$ 122,42M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 2 616 964 | 1,53% | US$ 100,70M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 2 350 000 | 1,37% | US$ 90,43M | 2026-03-31 |
| Invesco Ltd. | Institution | 2 259 649 | 1,32% | US$ 86,95M | 2026-03-31 |
| Holocene Advisors, LP | Institution | 2 250 196 | 1,32% | US$ 86,59M | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 2 113 551 | 1,24% | US$ 81,33M | 2026-03-31 |
| Venrock Healthcare Capital Partners III, L.P. | Institution | 2 084 386 | 1,22% | US$ 80,21M | 2025-06-30 |
| VR Management, LLC | Institution | 2 000 000 | 1,17% | US$ 76,96M | 2026-03-31 |
| D. E. Shaw & Co., L.P. | Institution | 1 868 389 | 1,09% | US$ 71,90M | 2026-03-31 |
| Pictet Asset Management Limited | Institution | 1 798 768 | 1,05% | US$ 69,22M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 714 927 | 1,00% | US$ 65,99M | 2026-03-31 |
| Artal Group S.A. | Institution | 1 709 279 | 1,00% | US$ 65,77M | 2026-03-31 |
| Marshall Wace LLP | Institution | 1 600 168 | 0,94% | US$ 61,57M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 1 516 297 | 0,89% | US$ 58,35M | 2026-03-31 |
| Woodline Partners LP | Institution | 1 509 557 | 0,88% | US$ 58,09M | 2026-03-31 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 1 422 666 | 0,83% | US$ 54,74M | 2025-06-30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
